Litcius/Paper detail

Imino‐ and Azasugar Protonation Inside Human Acid β‐Glucosidase, the Enzyme that is Defective in Gaucher Disease

Camilla Matassini, Julia Warren, Bo Wang, Andrea Goti, Francesca Cardona, Amelia Morrone, Mikael Bols

2020Angewandte Chemie International Edition26 citationsDOI

Abstract

Gaucher disease is caused by mutations in human acid β-glucosidase or glucocerebrosidase (GCase), the enzyme responsible for hydrolysis of glucosyl ceramide in the lysosomes. Imino- and azasugars such as 1-deoxynojirimycin and isofagomine are strong inhibitors of the enzyme and are of interest in pharmacological chaperone therapy of the disease. Despite several crystal structures of the enzyme with the imino- and azasugars bound in the active site having been resolved, the actual acid-base chemistry of the binding is not known. In this study we show, using photoinduced electron transfer (PET), that 1-deoxynojirimycin and isofagomine derivatives are protonated by human acid β-glucosidase when bound, even if they are completely unprotonated outside the enzyme. While isofagomine derivative protonation to some degree was foreshadowed by earlier crystal structures, 1-deoxynojirimycin derivatives were not believed to act as basic amines in the enzyme.

Topics & Concepts

ProtonationEnzymeChemistryGlucocerebrosidaseStereochemistryHydrolaseGaucher's diseaseHydrolysisBiochemistryDiseaseOrganic chemistryMedicinePathologyIonCarbohydrate Chemistry and SynthesisLysosomal Storage Disorders ResearchGlycosylation and Glycoproteins Research
Imino‐ and Azasugar Protonation Inside Human Acid β‐Glucosidase, the Enzyme that is Defective in Gaucher Disease | Litcius